Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-06-29 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
公司及中国银河证券股份有限公司关于审核问询函的回复（修订稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed response to a regulatory inquiry from the Shenzhen Stock Exchange regarding a company's application for a private placement of shares. It includes extensive information about the company's business qualifications, project descriptions, financial data, and regulatory compliance related to the issuance of new shares. The content focuses on the company's capital raising activities, specifically the issuance of shares to specific investors and the use of the raised funds. There is no indication that this is an annual report, earnings release, or other financial report. Instead, it is a detailed capital/financing update related to a share issuance process. Therefore, the document fits best under the category 'Capital/Financing Update' (CAP). The document length and detail support a high confidence in this classification.
2021-06-29 Chinese
中国银河证券股份有限公司关于公司向特定对象发行股票之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled '上市保荐书' which translates to 'Listing Sponsorship Letter' or 'Sponsorship Document for Stock Issuance'. It is issued by a securities company (中国银河证券股份有限公司) acting as the sponsor for Tianjin Ringpu Biotechnology Co., Ltd. regarding a specific stock issuance to certain investors. The content includes detailed information about the issuer, business operations, core technologies, financial data, risk factors, and regulatory compliance related to the stock issuance. This type of document is typically associated with capital raising activities and stock issuance processes rather than a general annual report or earnings release. It is not a transcript, audit report, or management change announcement. The document is comprehensive and exceeds 5,000 characters, containing substantive financial and business information related to a capital raising event. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP).
2021-06-29 Chinese
关于申请向特定对象发行股票的审核问询函回复（修订稿）的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding their response to a review inquiry letter from the Shenzhen Stock Exchange about their application for a private placement of shares. It discusses the review process, submission of revised responses, and the pending approval from regulatory authorities. The document is short (879 characters) and primarily serves as a disclosure notice about the status of a capital raising process, not the actual detailed report or financial statements. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to updates on company fundraising activities.
2021-06-29 Chinese
中国银河证券股份有限公司关于公司向特定对象发行股票之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled "证券发行保荐书" which translates to "Securities Issuance Sponsorship Letter" or "Securities Issuance Sponsorship Report". It is issued by China Galaxy Securities as the sponsor for Tianjin Ringpu Biotechnology Co., Ltd. regarding a specific issuance of A-shares to particular investors. The document contains detailed information about the issuance, the sponsor's due diligence, legal compliance, risk disclosures, and internal review procedures. It is a comprehensive report related to a capital raising event through a non-public stock issuance. This fits the definition of a Capital/Financing Update (CAP), as it provides updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive content, not merely an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2021-06-29 Chinese
向特定对象发行股票募集说明书（二次修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled "向特定对象发行股票募集说明书" which translates to "Private Placement Stock Issuance Prospectus" or "Offering Circular for Private Placement of Shares." It is issued by Tianjin Ringpu Biotechnology Co., Ltd. The content includes detailed information about the stock issuance, approval procedures, risk factors, use of proceeds, shareholder structure, and legal and regulatory compliance. It is a comprehensive disclosure document related to a capital raising event through a private placement of shares. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive information about the financing, not just an announcement or summary. Therefore, the appropriate classification is CAP with high confidence.
2021-06-29 Chinese
北京市康达律师事务所关于公司向特定对象发行股票的补充法律意见书（一）（修订稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion letter issued by a law firm regarding a company's specific stock issuance to particular investors. It discusses legal compliance, share issuance details, project funding, and related corporate governance matters. The document references a specific issuance of shares to particular investors and includes legal opinions on the fairness and compliance of the issuance process. It is not a financial report, earnings release, or audit report, but rather a legal opinion related to capital raising activities. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-06-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.